| Papers [1-14] of 100 :: [Page 1 of 8] | | Go to page : 1 2 3 4 5 6 7 8 —> | Search results on "INTERNATIONAL FINANCE PHARMACEUTICAL COMPANY": |
|
|
International Finance and Pharmaceutical Company, 2008.
A case study analysis of the financial and operating performance, as well as market performance of the Company, a fictional pharmaceutical company.
1,822 words (approx. 7.3 pages), 2 sources, APA, £ 41.95
»
Click here to show/hide summary
Abstract
This paper presents a policy statement by the Company, a fictional pharmaceutical company, that discusses concerns and expectations about market conditions in the coming year, which may impact the Company's operations and profitability. It provides a plan that may impact upon future financial and operating performance for the Company. It also looks at threats to the financial stability of the Company.
Table of Contents:
Pounds, Dollar, and Euros: Purchasing Power Parity
US Economy Strength and Expansion of R&D Capacity
German Competitor Introduction of Generic Detervin
Federal Reserve Interest Rates
Inflation Rate in Turkey Expected to be Very High
Price Volatility on the New York Stock Exchange
Interest Rates on Government Bonds in US and Germany
Conclusion
From the Paper
"The Company faces several challenges in the coming financial years, including managing subsidiary operations in a volatile and changing environment. The fact that much of the growth potential for the Company is found in its foreign subsidiaries implies that it will have to find ways to finance operations through local avenues increasingly going forward. As the strength of the British pound become diluted closer to historical norms over time, the growth in subsidiaries should allow to the Company to increase both its operating and profit performance. Therefore, the coming year should represent significant opportunities to positively impact future growth with management's efforts to capitalize on market challenges around the world."
| |
|
Pharmaceutical Company and Industry Analysis, 2001.
A company analysis of Merck & Company, INC., a pharmaceutical company.
5,390 words (approx. 21.6 pages), 30 sources, £ 93.95
»
Click here to show/hide summary
Abstract
This paper analyzes pharmaceutical company, Merck & Company, INC., . The author provides a company profile and examines a number of issues such as: product marketing, service marketing, manufacturing, values and motives of the company.
From the Paper
"The pharmaceutical industry is one of the largest and most far reaching industries in our nation, and therefore is an industry that can neither be avoided nor ignored. The amount of money spent on healthcare is phenomenal ? representing 14 cents of every dollar of goods and services produced in the United States (Jhin, 1996). New drugs that emerged in the past decade proved to be extremely profitable, and with new advances in technology and faster drug approval rates, the outcome is clear ? more money plus better science equals more new drugs (Kleinke, 1998). "
| |
|
International Trade and Finance Law, 2005.
An examination of international trade and finance law.
3,643 words (approx. 14.6 pages), 10 sources, MLA, £ 71.95
»
Click here to show/hide summary
Abstract
This paper examines the procedures involved in international trade and finance law by comparing US international trade procedures to international trade procedures estabilshed by the UN. The paper explains the various international payment methods and the methods of unification and then looks at the obstacles in place that make international trade difficult. The writer believes that the primariy difficulty regarding international trade is the interest that politicians take in the matter and the overall financial position of the countries that are involved. The writer concludes that this is turn makes trading difficult as obstacles are put in the path of trade for the benefit of individual countries.
Outline:
Introduction
Analysis
Conclusion
From the Paper
"The question for any international trade is the guarantee of payment to be received by the seller. In natural course, the items to or services sold are first received by the buyer and then only the payments are sent. In the case of any individual country, there are laws within the country to ensure that the payments are made by the buyer, but in the international scene, the differences between different countries may cause difficulties. The procedure that is now adopted is to follow certain procedures that have been set up under the auspices of United Nations. The international procedures have to be competed with a national procedure for a country for us to understand the comparative position. For this purpose, the position of United States has been used."
| |
|
Pfizer Pharmaceutical Company, 2004.
An analysis of the marketing success of the Pfizer Pharmaceutical Company.
1,938 words (approx. 7.8 pages), 6 sources, MLA, £ 43.95
»
Click here to show/hide summary
Abstract
This paper examines how Pfizer is one of the most successful pharmaceutical companies in existence and how much, if not most, of Pfizer?s success is due to the corporation?s marketing genius, which is considered to be among the best in the industry. It looks at how Pfizer also has one of the best safety records in the industry, which helps in gaining investors and trust in the company. It also explores how, unlike most large corporations, Pfizer draws revenue from a limited number of products.
Outline
Company Structure and Marketing Strategies
Marketing Strengths
Threats
From the Paper
"The marketing principles utilized by Pfizer guides every aspect of the corporation?s business. There are five main principles that are fundamental to Pfizer?s business practices. First, the work conducted by Pfizer is grounded in science. With solid clinical research as a foundation, Pfizer?s marketing group uses its credibility and knowledge to develop important relationships within the medical community. Second, Pfizer takes an integrated approach to its marketing strategies. Innovation is promoted through the encouragement of teamwork within and across marketing groups. This also allows Pfizer to respond flexibly and promptly to changes in the market."
| |
|
The Walgreen's Pharmaceutical Company, 2002.
Analysis of a marketing strategy for Walgreen's Pharmaceutical Company.
1,900 words (approx. 7.6 pages), 6 sources, £ 50.95
»
Click here to show/hide summary
Abstract
This paper examines the strategic implementation of a marketing strategy for the Walgreen's Pharmaceutical Company. The author states clear objectives, and discusses products, promotion, services offered, price strategy, and methods of maintaining strategic competence.
| |
|
International Banking and Finance, 2008.
A discussion of issues related to international finance.
1,315 words (approx. 5.3 pages), 10 sources, APA, £ 31.95
»
Click here to show/hide summary
Abstract
This document discusses several questions related to international banking and finance. Some of the issues discussed are related to the character of the global economy and how its financial mechanisms are now interconnected. Additionally, some of the developments related to globalization are examined. And finally, the various aspects of the Asian and Mexican currency crises are examined with a view to the global financial markets that enabled them.
Table of Contents:
Abstract
Consolidation of Financial Markets
Outsourcing and Offshoring
The Asian and Mexican Financial Crises
From the Paper
"In the same way that the Asian financial crisis played out in individual markets such as South Korea, the Mexican currency crisis also began during a period when there was actually much promising economic outlook. During the 1980s the Mexican government liberalized its trade sectors and during the early 1990s had brought its inflation under control to below 10% which was good for that market. With these and other economic reforms beginning to take effect in the country, Mexico's economic prospects appeared strong."
| |
|
International Finance, 2005.
This paper discusses the issue of international finance and trade.
900 words (approx. 3.6 pages), 1 source, £ 22.95
»
Click here to show/hide summary
Abstract
In this article, the writer discusses managing risk in international trade. The paper addresses the matter of the identification of the financial risks of conducting business internationally. The writer examines the significance of foreign exchange rate risk. Further, the writer discusses how this risk can be mitigated.
From the Paper
"International trade is an important factor in stimulating growth in the U.S. economy. Most economists agree that international trade and the theories of absolute advantage as well as comparative advantage, as they relate to international trade boost economic growth and improve the standard of living of the average American. However, doing business internationally is not without risk. For example, even if a company opts to export goods rather than to locate business operations in a foreign country, it still faces the possibility that ... "
| |
|
International Finance, 2008.
This paper looks at international finance and discusses national reserves.
1,117 words (approx. 4.5 pages), 4 sources, APA, £ 27.95
»
Click here to show/hide summary
Abstract
In this article, the writer looks at the central bank, which is one of the most important institutions in a country and whose main responsibility is the national monetary policy. The writer notes that many countries can improve the efficiency of their foreign currency reserve by investing the money and generating a return. The writer also points out that, on a global level, the increased efficiency of a central bank's use of reserve would translate into a reduction of financial crises, which would allow institutions such as the International Monetary Fund to redirect its funds to countries that are not yet capable to reach financial stability as well as design policies for those countries targeting their future stability. The writer notes that these are usually third world countries or developing countries with endemic corruption and political instability.
Outline:
The Central Bank - Roles
Reserves Policy - Evidence from Developing Countries
Central Banks and Foreign Currency Reserve Policy Efficiency
From the Paper
"A healthy reserve policy can overcome financial crises, such as those related to the country's balance sheet. Korea stands as a good example in this direction with its 1997 crisis. Investment banks started to borrowed short maturity foreign currencies and invested them in Korean won assets after the market deregulation in 1990. The same banks invested in foreign securities Russian bonds and by the end of 1997 the value of these obligations exceeded Korea's foreign currency reserves. In the context of a general fall of Asian currencies, the investors started to sell the Korean won, which eventually devaluated the national currency and forced the authorities to resort to the International Monetary Fund. The problem was not that Korean wasn't solvent, but that it wasn't liquid and this crisis could have been avoided, if the authorities hadn't let the national liquidity deteriorate so much since the beginning of 1990s."
| |
|
Social Responsibility of Pharmaceutical Companies, 2004.
Study of the ethics of pharmaceutical companies when conducting business and promoting their products.
5,370 words (approx. 21.5 pages), 32 sources, MLA, £ 93.95
»
Click here to show/hide summary
Abstract
This paper addresses several questions concerning the ethical conduct of pharmaceutical companies. The paper considers whether doctors that sit on the boards of companies can be impartial when they make decisions to financially back research/drugs of the pharmaceutical company they represent, as well as what should be the corporate responsibility of the pharmaceutical companies. Also considered is whether pharmaceutical companies have systems in place to keep them ethically responsible and if advertising by pharmaceutical companies actually creates a demand for prescriptions when no need actually exists. Numerous graphs and tables are included.
From the Paper
"Indeed, one of the unique aspects of advertising prescription pharmaceuticals is the caveat ?Ask your doctor?. The consumer cannot go out and directly purchase the product (note that via the internet this is now possible), but traditionally must receive a physician?s endorsement by way of a prescription. The pharmaceutical industry uses this reasoning to defend its promotional tactics, claiming that because doctors ultimately authorize prescriptions the public is insulated from deceptive advertising. Yet research indicates that doctors are likely to prescribe drugs patients request under increasing pressure. Patients often insist on brand names over generic drugs, some of which are just as effective and less costly."
| |
|
Wyeth Pharmaceuticals Company, 2008.
Describes the Wyeth Pharmaceuticals Company from the perspective of being an employee of the company.
1,845 words (approx. 7.4 pages), 12 sources, APA, £ 41.95
»
Click here to show/hide summary
Abstract
This paper presents an overview of the Wyeth Pharmaceuticals Company. The paper relates that Wyeth Pharmaceuticals is the globe's biggest pharmaceutical and healthcare company and that it holds the premier position among the 35 pharmaceutical companies present globally for patent based intellectual property. The paper also provides some additional statistics about Wyeth and then discusses the company's financial outcomes, state of competition and strengths. The paper concludes with a discussion on the process of product life cycle management at the company. Financial data about the Wyeth is also included with the paper.
Table of Contents:
Financial Outcomes
The Global Pharmaceutical Scenario and State of Competition
Wyeth's Product Strengths
Unique R&D - Our Core Strength
Learn & Confirm - A New Paradigm
Pharmaceuticals - A Knowledge Driven Industry
Product Life Cycle Management-A Sunrise Business Process for Pharmaceutical Industry
Financial Highlights
Selected Financial Data
Worldwide Net Revenue by Product
From the Paper
"In the sphere of consumer healthcare products, our company is a leader in research, development, production, and marketing of wide range of consumer healthcare products running in more than 65 nations. Our sales figures for the year 2006 have touched $2.5 billion, and Wyeth Consumer Healthcare is among the biggest OTC healthcare product in the entire world with workforce strength of 3200. The commitment of our company in improving the healthcare across the world has transformed Wyeth Consumer Healthcare into a top ranked competitor in excess of a dozen vital product categories inclusive of analgesic, cough cold allergy and vitamin/ nutritional supplements."
| |
|
Pharmaceutical Company Ethics: Profit Before People, 2001.
An examination of the ways in which the pharmaceutical industry manipulates the system, people and doctors in an effort to maximize their profits.
3,000 words (approx. 12.0 pages), 18 sources, MLA, £ 62.95
»
Click here to show/hide summary
Abstract
This paper takes an in depth look at the ways in which pharmaceutical companies unscrupulously put profit before people. Five of the main ways in which they do this that are discussed are; manipulation of research, undue influence over doctors prescribing practices, direct-to-consumer advertising, discrediting of their competitors pharmaceutical and natural alike, and investing only in profitable research. Each topic is discussed thoroughly with credible sources to back the data up.
From the Paper
"The pharmaceutical industry wants people to believe that their main goal is to help people. The Pharmaceutical Research and Manufacturers of America (PhRMA) has even begun airing feel-good commercials featuring people whose lives have been saved by medications. In reality, they spend billions of dollars every year to ensure their true purpose, maximum profit. Their influence begins in the research lab, where the sponsor, usually a pharmaceutical company with a huge financial stake in the findings, has more to say over how the study is conducted and what information is released then the actual investigators, leading some of the foremost medical journals in the world to fight back with strict guidelines. After the pharmaceutical companies get their products approved, they engage in a campaign of bribery to persuade doctors to prescribe their name brand, expensive drugs over their competitor's products. Not wanting to leave it up to the doctors alone to endorse their products, the pharmaceutical industry has started advertising directly to an unwitting populace, on television and in popular magazines. Pharmaceutical companies use their political power and vast economic resources to discredit and undermine non-drug treatment options for various diseases, particularly by attacking the burgeoning field of holistic medicine. Furthermore, the pharmaceutical companies have a long history of not investing in research that would lead to drugs for diseases that effect the world's poor, because there is little profit to be made in developing nations. Through various immoral practices, the pharmaceutical companies put profit ahead of the interests, health and safety of consumers. "
| |
|
International Trade and Finance Law, 2006.
This paper discusses how international trade works and includes the legal viewpoint.
3,639 words (approx. 14.6 pages), 11 sources, MLA, £ 71.95
»
Click here to show/hide summary
Abstract
The paper begins by explaining the procedures of international trade. The paper discusses the laws within a country that ensure the payments are made by the buyer, but in the international scene, the differences between different countries may cause difficulties. The paper describes how the United Nations Convention on International Bills of Exchange and International Promissory Notes was set up which
determines standards for bills of exchanges. This forms the basic mechanism for payment of any trade or commerce. The paper discusses the success of international traders and concludes that the financial aspect of international trade depends a lot on political situations and the overall financial position of the countries that are involved.
Contents:
Introduction
Analysis
Conclusion
From the Paper
"For determining procedures of setting up standards for bills of exchanges, which form the basic mechanisms for payment of any trade or commerce, a United Nations Convention on International Bills of exchange and International Promissory Notes was set up. The concerned work was done over fifteen years by the United Nations Commission on International Trade Law -- UNCITRAL. This was adopted by the General Assembly of the United Nations, after being recommended by the Sixth Legal Committee on 9 December 1988. The matter proceeded in steps and UNCITRAL first consulted with the International Institute for the Unification of Private Law -- UNIDROIT as that organization had previously addressed the subject of unification of law regarding negotiable instruments. This required UNIDROIT to first prepare a report on the chances of extending the unification of the law regarding bills of exchange and checks."
| |
|
International Corporate Finance, 2005.
Examines the issues of corporate finance and government intervention from a global perspective.
2,314 words (approx. 9.3 pages), 5 sources, APA, £ 50.95
»
Click here to show/hide summary
Abstract
Perhaps the first issue addressed in this paper is a consideration of the possible conflict caused by various governmental regulations on the corporate goal of increasing shareholder wealth is this: Is there any effect? The second question examined-and perhaps the more important one in today's global business and social environment-is this: Is the maximization of shareholder wealth the appropriate goal for a business entity? The paper shows that, indeed, with Europe embracing human rights as a major issue, and in view of the current divisive atmosphere in the United States concerning both corporate governance and governmental transfer payment restructuring (Social Security), it seems advisable to consider these questions from a broad-based global perspective and also from the perspective of other 'stakeholders' in global business besides the shareholder. These stakeholders would include, of course, all citizens of the globe and not merely those with sufficient income to become stakeholders.
Paper Outline:
Introduction
Tavis' Model
Demonstrations from the Shareholder Norm
References
From the Paper
"While that is a normative theory that gives rise to a complex of actions, the stakeholder theory proposed by Tavis "is more of a description of who has a stake in the activities of the firm than a normative theory" (2002 Database). Tavis quotes R. Edward Freeman, who defined stakeholders: "A stakeholder in an organization is (by definition) any group or individual who can affect or is affected by the achievement of the organization's objectives" (2002, Database). This much more inclusive definition makes it clear that unless a corporation is living on a planet of its own, a closed and moreover perfect system of equality of risk, reward, 'collateral damage' and any effect imaginable, then it is incumbent on management of that corporation to consider not merely the shareholders as traditionally defined."
| |
|
International Finance and Foreign Exchange Risk, 2004.
A look at some of the risks companies assume when conducting international business.
2,925 words (approx. 11.7 pages), 9 sources, APA, £ 73.95
»
Click here to show/hide summary
Abstract
This paper discusses the importance of foreign exchange risk and the potential that risk has for harming a firm involved in global operations. The paper then examines what a company can do to manage foreign exchange risks.
|
|
|
